Overview of the 2023 FDA Circulatory System Devices Advisory Panel meeting on the Recor Paradise Ultrasound‐Based Renal Denervation System
Catheterization and Cardiovascular Interventions · 2024
DOI: 10.1002/ccd.31065 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Catheterization and Cardiovascular Interventions, 2024. Verfasst von Dan Haberman und 4 weiteren Autor:innen. Beteiligte Einrichtung: Section of Interventional Cardiology, MedStar Washington Hospital Center, Washington, District of Columbia, USA. Hauptthemen laut MEDLINE: United States Food and Drug Administration, Sympathectomy, Hypertension, Renal Artery. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 18 Literaturangaben.
Abstract (Originalsprache)
Hypertension continues to be a prominent, avoidable factor contributing to major vascular issues on a global scale. Even with lifestyle adjustments and more aggressive medical treatments, maintaining optimal blood pressure levels remains challenging. This challenge has driven the emergence of device‐oriented approaches to address hypertension. To assess the safety and efficacy of the Recor Paradise Ultrasound Renal Denervation System, the Circulatory System Devices Panel was convened by the US Food and Drug Administration (FDA). This manuscript provides a condensed overview of the information put forth by the sponsor and the FDA, along with an account of the considerations and conversations that took place during the meeting.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Section of Interventional Cardiology, MedStar Washington Hospital Center, Washington, District of Columbia, USA.
ORCID-Profile: Ron Waksman
Zitieren
APA
Haberman, D., Chitturi, K. R., Lupu, L., Wermers, J. P., & Waksman, R. (2024). Overview of the 2023 FDA Circulatory System Devices Advisory Panel meeting on the Recor Paradise Ultrasound‐Based Renal Denervation System. Catheterization and Cardiovascular Interventions. https://doi.org/10.1002/ccd.31065
Vancouver
Haberman D, Chitturi KR, Lupu L, Wermers JP, Waksman R. Overview of the 2023 FDA Circulatory System Devices Advisory Panel meeting on the Recor Paradise Ultrasound‐Based Renal Denervation System. Catheterization and Cardiovascular Interventions. 2024. doi:10.1002/ccd.31065
BibTeX
@article{Haberman2024,
author = {Haberman, Dan and Chitturi, Kalyan R and Lupu, Lior and Wermers, Jason P and Waksman, Ron},
title = {Overview of the 2023 FDA Circulatory System Devices Advisory Panel meeting on the Recor Paradise Ultrasound‐Based Renal Denervation System},
journal = {Catheterization and Cardiovascular Interventions},
year = {2024},
doi = {10.1002/ccd.31065}
}
EUVIMED